Parkinson’s – Autologous Stem Cell Therapy Results (N=50)
Parkinson’s disease (also known as Parkinson disease or PD) is a degenerative disorder of the central nervous system that often impairs the sufferer’s motor skills, speech, and other functions.
Parkinson’s disease belongs to a group of conditions called movement disorders. It is characterized by muscle rigidity, tremor, a slowing of physical movement (bradykinesia) and a loss of physical movement (akinesia) in extreme cases. The primary symptoms are the results of decreased stimulation of the motor cortex by the basal ganglia, normally caused by the insufficient formation and action of dopamine, which is produced in the dopaminergic neurons of the brain. Secondary symptoms may include high level cognitive dysfunction and subtle language problems. PD is both chronic and progressive.
50 patients with Parkinson’s disease were treated with Autologous stem cells by the XCell-Center. Injection of the Stem Cells was performed by Lumbar Puncture. 200 ml of Bone Marrow was extracted out of the Iliaca crest and was concentrated for transplantation using gradient centrifugation. After treatment, the patients were evaluated using a post treatment survey. The results are presented below.
Nearly 60% of patients treated reported an improvement in their condition after treatment.
The average patient age was 65 years old. Patients as young as 38 years old and as old as 85 years old were treated. 80% were female. The average follow-up time was 7 months after treatment. Most patients experienced improvements after a couple of months.
Approximately 60% of improved patients reported better speech, handwriting and ability to use utensils. About 1/3 experienced improved ability to swallow and control saliva (drooling).
3 out of 4 patients who improved experienced decreased rigidity and a little more than half reported decreased tremors. Over 85% reported improved walking ability. While greater than 80% experienced improved gait.
60% of patients who reported improvements had them confirmed by their personal physician.
Approximately 40% of all improved patients reduced or eliminated their use of Parkinson’s medications.
In a Patient’s Own Words
Johannes Wolf – 72 years old
“…I no longer have any pain and I am completely drug free…”
Aubra Phillips – 59 years old
“…After the stem cell treatment I would no longer freeze…”
Ted Ebertsch – 66 years old
“…My neurologist saw me during this time and confirmed that I looked like I was doing very well…”
Jon Andresen – 71 years old
“…Now, I am walking like I was before I had Parkinson’s…”
Jankovic J (April 2008). “Parkinson’s disease: clinical features and diagnosis”. J. Neurol. Neurosurg. Psychiatr. 79 (4): 368-76
- Neuroplasticity Can Prevent Alzheimer’s According To This Study
- GE Healthcare to Form Coalition Targeting Neurodegenerative Diseases : Press Releases : News : GE
- Virtual reality-based exercises to aid Parkinson’s disease patients
- What predicts mortality in Parkinson disease?
- Application for iPhone may help monitor Parkinson’s disease
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- March 2009
- November 2008
- October 2008
- September 2008
- July 2008
- May 2008